AbbVie, Inc. (ABBV) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Eli Lilly & Co.

Vertex Pharmaceuticals, Inc.

Zoetis, Inc.

Bristol Myers Squibb Co.

Pfizer Inc.

Regeneron Pharmaceuticals, Inc.

Johnson & Johnson

AbbVie, Inc.

Merck & Co., Inc.

Seagen Inc.

Horizon Therapeutics Plc

Why is AbbVie, Inc. ?

High Debt company with Weak Long Term Fundamental Strength

High Debt Company with a Debt to Equity ratio (avg) at times

Flat results in Jun 25

INVENTORY TURNOVER RATIO(HY) Lowest at 3.69 times
CASH AND EQV(HY) Lowest at USD 11,643 MM
INTEREST(Q) Highest at USD 782 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 28.45%, its profits have risen by 16.2% ; the PEG ratio of the company is 1.4

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is AbbVie, Inc. for you?

Low Risk, High Return

Absolute

Risk Adjusted

Volatility

AbbVie, Inc.

19.17%

1.19

26.28%

S&P 500

22.99%

0.70

20.15%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

5.95%

EBIT Growth (5y)

6.49%

EBIT to Interest (avg)

7.46

Debt to EBITDA (avg)

2.38

Net Debt to Equity (avg)

45.57

Sales to Capital Employed (avg)

0.79

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

281.66%

Pledged Shares

Institutional Holding

76.07%

ROCE (avg)

25.94%

ROE (avg)

300.50%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

-115.40

EV to EBIT

21.91

EV to EBITDA

15.55

EV to Capital Employed

7.46

EV to Sales

7.19

PEG Ratio

Dividend Yield

3.11%

ROCE (Latest)

34.04%

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

No Trend

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

DIVIDEND PER SHARE(HY)

Highest at USD 5.03

RAW MATERIAL COST(Y)

Fallen by -2.8% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 5.03 times

-7What is not working for the Company

NET PROFIT(HY)

At USD 6,639.26 MM has Grown at -26.64%

ROCE(HY)

Lowest at 0%

Here's what is working for AbbVie, Inc.

Dividend per share

Highest at USD 5.03 and Grown

In each year in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (USD)

Debtors Turnover Ratio

Highest at 5.03 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -2.8% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for AbbVie, Inc.

Net Profit

At USD 6,639.26 MM has Grown at -26.64%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)